CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	12 Months Ended			213 Months Ended
	Jul. 31, 2013	Jul. 31, 2012	Jul. 31, 2011	Jul. 31, 2013
Income Statement [Abstract]
Revenues, net		$ 28,651	$ 291,628	$ 5,110,784
Cost of Goods Sold		11,109	155,619	1,620,375
Gross profit		17,542	136,009	3,490,409
Operating Expenses:
Research and development	2,192,724	4,987,236	10,250,397	134,168,688
Research and development - related party				220,218
Selling and marketing		165,175	1,025,774	9,333,214
General and administrative	3,936,635	4,889,179	13,392,920	151,738,791
General and administrative - related party				314,328
Total Operating Expenses	6,129,359	10,041,590	24,669,091	295,775,239
Operating Loss	(6,129,359)	(10,024,048)	(24,533,082)	(292,284,830)
Other Income (Expense):
Miscellaneous income (expense)			489,292	686,303
Income from assets held for investment, net (Note 3)	1,245,165	2,206,216	349,458	5,579,422
Interest income	353	1,519	6,455	7,782,246
Interest expense	(530,222)	(592,525)	(208,906)	(69,538,904)
Change in fair value of derivative liabilities (Note 10)	(3,140,259)	(1,081,440)	2,220,916	(3,856,236)	[1]
Loss on extinguishment of debt				(14,134,068)
Net Loss Before Undernoted	(8,554,322)	(9,490,278)	(21,675,867)	(365,766,067)
Minority Interest Share of Loss				3,038,185
Net Loss	(8,554,322)	(9,490,278)	(21,675,867)	(362,727,882)
Preferred Stock Dividend	1,722,474	376,746	766,417	5,160,694
Net Loss Available to Common Stockholders	$ (10,276,796)	$ (9,867,024)	$ (22,442,284)	$ (367,888,576)
Basic and Diluted Net Loss Per Common Share (Note 14) (in dollars per share)	$ (0.02)	$ (0.03)	$ (0.08)
Weighted Average Number of Shares of Common Stock Outstanding - basic and diluted (Note 14) (in shares)	443,579,247	332,333,583	284,818,486

[1] Includes $5,981,403 as adjustment related to the adoption of FASB ASC Topic 815 in "Cumulative from November 2, 1995 (Date of Inception) to July 31, 2013" column. See Note 10 - Derivative Liabilities.